awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q55658098-18E2030F-68D9-474D-8959-05E51310E08D
Q55658098-18E2030F-68D9-474D-8959-05E51310E08D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q55658098-18E2030F-68D9-474D-8959-05E51310E08D
Recent advancements in esophageal cancer treatment in Japan.
P2860
Q55658098-18E2030F-68D9-474D-8959-05E51310E08D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q55658098-18E2030F-68D9-474D-8959-05E51310E08D
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
4da33697d967ae4e697a8226384314e83e426e69
P2860
Peri-operative chemotherapy with or without bevacizumab in operable oesophagogastric adenocarcinoma (UK Medical Research Council ST03): primary analysis results of a multicentre, open-label, randomised phase 2-3 trial.